None listed
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Age: 35 to 50 years (inclusive) at the time of consent. 2. Sex: Males and Non-pregnant/Non-lactating Females (preferably equal numbers of males and females). 3. Females of Childbearing potential must have a negative urine pregnancy test performed on screening visit and agree to follow an accepted method of birth control for the duration of the study. 4. Corporate Subjects with complaint of feeling exhausted with routine and impaired due to lack of energy. 5. Subjects with ability to understand and willingness to sign and date a written Informed Consent Document at the screening visit before any protocol- specific procedures are performed. 6. Subjects willing to follow all study instructions and report to facility for all follow-up visits.
Exclusion criteria
Exclusion criteria: 1. Subjects with acute and chronic diseases (including diabetes, inflammatory bowel diseases, dementia, multiple sclerosis). 2. History of substance or alcohol abuse within the last 2 years. 3. Subjects who are using additional suppliments, using medications (e.g. antihypertensive medications, lipid reducers, thyroid medication). 4. Female subjects who are Pregnant or lactating women. 5. Any individual who is involved with conduct of this study. 6. Subjects who have participated in another study with any investigational product within 3 months of randomization. 7. Subject having history of/or currently using medication which in the opinion of the investigator may affect the evaluation of the study product, or place the participant at undue risk. 8. Any disease or condition that in the opinion of the investigator and/or sponsor may interfere with the completion of the study evaluation.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1.Subjective perception about test products •Lifestyle related questionnaires •Symptoms on energy level •Satiety Level Timepoint: 1.Day 01 to Day 15 and Day 30 | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Safety of test products will be determined by adverse event, if any, reported by the Principal Investigator along with self-reported by subjects.Timepoint: 1. Day 01 to Day 15 and Day 30 | — |
Countries
India
Contacts
Cliantha Research